Relevare Of Australia Names New Chairman To Raise Funds, Set Goals
This article was originally published in PharmAsia News
Executive Summary
Australia's Relevare Pharmaceuticals, a small biotechnology company with a cancer painkiller in development, has named a new chairman for its board of directors